The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Dr. Cees Van Kooten studied biology in Amsterdam with specializations in immunology and molecular biology and in 1992 he successfully defended his thesis, entitled “The role of cytokines in the activation of human malignant B cells”. Subsequently, he spent two years as a postdoctoral fellow at the immunological research Institute from Schering Plough, Lyon France, where he studied the molecular interactions between T-and B-cells. In 1995, Dr. van Kooten moved to the Department of Nephrology in Leiden and received a fellowship of the Royal Dutch Academy of Science (KNAW) to investigate the role of CD40-CD40L in the rejection of transplanted kidneys. In 2003 he became associate professor and in 2009 he was appointed as professor in Experimental Nephrology and Transplant Immunology at the Leiden University Medical Center. Dr. van Kooten is (co) author of over 250 scientific articles. He has garnered substantial research grants, and has been active in reviewing both for scientific journals as well as for grant organizations. Dr. van Kooten has introduced innovative research in Leiden and is now regarded as one of the leading researchers in his field, which is at the crossroad of immunology, transplantation and nephrology. The connecting theme of this research is the role of the innate immune system in renal inflammation and graft rejection, covering both the cellular (DC and other antigen presenting cells) and humoral components (complement).
